Wednesday, September 5, 2018

BCG Fibromyalgia Vaccine Trials Receive FDA Approval

As I stated in a blog I wrote in July (2018), the FM/a® Test is making a huge impact on the way fibromyalgia is diagnosed and now it is being used for very important research into the cause and treatment of our symptoms. - treatment

In April of 2017, I reported on a press release.  Excerpts:

EpicGenetics to detect fibromyalgia disease-specific gene markers. Additionally, Bruce Gillis, M.D., CEO of EpicGenetics, has made a research gift to the Immunobiology Laboratory at the Massachusetts General Hospital directed by Denise Faustman, M.D., Ph.D., to continue its robust clinical research regarding a direct treatment for fibromyalgia. 

The FM/a® Test is an FDA-compliant blood test that diagnoses fibromyalgia by identifying the presence of specific white blood cell abnormalities that have been documented to exist in these patients…

Based upon the findings of [Whole-Exome genetic] testing and once treatment protocols have received regulatory and institutional approvals, FM/a® Test positive patients will be invited to participate in a fibromyalgia-specific vaccine clinical trial to reverse the biology of fibromyalgia…

Today, I would to share with you “…the Food and Drug Administration (FDA) has approved the clinical trial of the BCG vaccine to treat fibromyalgia.”

Dr. Bruce Gillis, CEO of Epicgenetics, says, "This trial has the potential to impact the biology of fibromyalgia and now with clinical testing, it will be determined over the next four years whether this vaccine has clinical validity, as well.  Since the generic BCG vaccine is affordable and safe, the clinical trial introduction of this vaccine will perhaps transform the live of the patients who currently have no other direct treatments available to combat this very debilitating disease."

These are exciting times thanks to Dr. Gillis and others who desire to do away with the same labels and stereotypes once suffered by those with SLE (Lupus) and MS (multiple sclerosis) prior to having technology that allows physicians to make a diagnose. Because of his generosity and persistence, despite the naysayers supported by Big Pharma, we will get answers to some very important questions.

1.     Are there genetic factors that can identify the risk of developing fibromyalgia, like the BRCA gene indentifies breast cancer risk?
2.     Can the immune cell dysfunction found in fibromyalgia patients using the FM/a Test be treated with an old, safe, and cheap vaccine that is showing promise as a treatment for type-1 diabetes, and nearly irradiated tuberculosis?

This important, responsible randomized, double blind clinical trial could result in restoring the quality of life for those of us with fibromyalgia. The trial will be over four years. So, if you would like to be a candidate,


You will also find answers to frequently asked questions, a brochure to download, personal testimonies, access to peer-reviewed medical publications, and a scrolling list of insurance companies known to cover the test (at the bottom of the page). In addition, there is plenty of information to answer questions like why me, and how do I know if I am a candidate for the FM/a Test?  If you have more questions, you are encouraged to give their staff a call.

Additional Reading:

In healing,

Celeste Cooper, RN / Author, Freelancer, Advocate

Think adversity?-See opportunity!

~ • ~ • ~ • ~ • ~ • ~

Learn more about Celeste’s books here. Subscribe to posts by using the information in the upper right hand corner or use the share buttons to share with others. 

No comments:

Celeste's Website

Celeste's Website
Click on the picture